These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


380 related items for PubMed ID: 8977598

  • 1. Effect of regular terbutaline on the airway response to inhaled budesonide.
    Wilding PJ, Clark MM, Oborne J, Bennett JA, Tattersfield AE.
    Thorax; 1996 Oct; 51(10):989-92. PubMed ID: 8977598
    [Abstract] [Full Text] [Related]

  • 2. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
    de Jong JW, van der Mark TW, Koëter GH, Postma DS.
    Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
    [Abstract] [Full Text] [Related]

  • 3. Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge.
    Wong CS, Wahedna I, Pavord ID, Tattersfield AE.
    Am J Respir Crit Care Med; 1994 Nov; 150(5 Pt 1):1268-73. PubMed ID: 7952551
    [Abstract] [Full Text] [Related]

  • 4. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.
    Hancox RJ, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Taylor DR.
    Respir Med; 2000 Aug; 94(8):767-71. PubMed ID: 10955752
    [Abstract] [Full Text] [Related]

  • 5. Budesonide and terbutaline or terbutaline alone in children with mild asthma: effects on bronchial hyperresponsiveness and diurnal variation in peak flow.
    Waalkens HJ, Gerritsen J, Koëter GH, Krouwels FH, van Aalderen WM, Knol K.
    Thorax; 1991 Jul; 46(7):499-503. PubMed ID: 1877037
    [Abstract] [Full Text] [Related]

  • 6. Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma.
    Aldridge RE, Hancox RJ, Robin Taylor D, Cowan JO, Winn MC, Frampton CM, Town GI.
    Am J Respir Crit Care Med; 2000 May; 161(5):1459-64. PubMed ID: 10806139
    [Abstract] [Full Text] [Related]

  • 7. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma.
    Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Reinikainen K, Selroos O.
    N Engl J Med; 1991 Aug 08; 325(6):388-92. PubMed ID: 2062329
    [Abstract] [Full Text] [Related]

  • 8. Relative effects of inhaled corticosteroids on immunopathology and physiology in asthma: a controlled study.
    Burke CM, Sreenan S, Pathmakanthan S, Patterson J, Schmekel B, Poulter LW.
    Thorax; 1996 Oct 08; 51(10):993-9. PubMed ID: 8977599
    [Abstract] [Full Text] [Related]

  • 9. Randomised trial of an inhaled beta2 agonist, inhaled corticosteroid and their combination in the treatment of asthma.
    Hancox RJ, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Wong CS, Taylor DR.
    Thorax; 1999 Jun 08; 54(6):482-7. PubMed ID: 10335000
    [Abstract] [Full Text] [Related]

  • 10. Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators.
    van der Molen T, Postma DS, Turner MO, Jong BM, Malo JL, Chapman K, Grossman R, de Graaff CS, Riemersma RA, Sears MR.
    Thorax; 1997 Jun 08; 52(6):535-9. PubMed ID: 9227720
    [Abstract] [Full Text] [Related]

  • 11. Use of a fixed combination beta 2-agonist and steroid dry powder inhaler in asthma.
    Barnes PJ, O'Connor BJ.
    Am J Respir Crit Care Med; 1995 Apr 08; 151(4):1053-7. PubMed ID: 7697230
    [Abstract] [Full Text] [Related]

  • 12. Long-term intervention in childhood asthma: the Dutch study results. Dutch Chronic Nonspecific Lung Disease Study Group.
    van Essen-Zandvliet EE.
    Monaldi Arch Chest Dis; 1995 May 08; 50(3):201-7. PubMed ID: 7663491
    [Abstract] [Full Text] [Related]

  • 13. Effects of cessation of terbutaline treatment on airway obstruction and responsiveness in patients with chronic obstructive pulmonary disease.
    de Jong JW, Koëter GH, van der Mark TW, Postma DS.
    Thorax; 1996 Jul 08; 51(7):684-8. PubMed ID: 8882073
    [Abstract] [Full Text] [Related]

  • 14. Tolerance to beta-agonists during acute bronchoconstriction.
    Hancox RJ, Aldridge RE, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Town GI, Taylor DR.
    Eur Respir J; 1999 Aug 08; 14(2):283-7. PubMed ID: 10515402
    [Abstract] [Full Text] [Related]

  • 15. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma.
    Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Selroos O, Sovijärvi A.
    N Engl J Med; 1994 Sep 15; 331(11):700-5. PubMed ID: 8058076
    [Abstract] [Full Text] [Related]

  • 16. Randomised placebo controlled trial of beta agonist dose reduction in asthma.
    Harrison TW, Oborne J, Wilding PJ, Tattersfield AE.
    Thorax; 1999 Feb 15; 54(2):98-102. PubMed ID: 10325911
    [Abstract] [Full Text] [Related]

  • 17. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma.
    Vathenen AS, Knox AJ, Wisniewski A, Tattersfield AE.
    Am Rev Respir Dis; 1991 Jun 15; 143(6):1317-21. PubMed ID: 2048819
    [Abstract] [Full Text] [Related]

  • 18. Effect of an inhaled glucocorticosteroid on mast cell and smooth muscle beta 2 adrenergic tolerance in mild asthma.
    Yates DH, Worsdell M, Barnes PJ.
    Thorax; 1998 Feb 15; 53(2):110-3. PubMed ID: 9624295
    [Abstract] [Full Text] [Related]

  • 19. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.
    Kraan J, Koëter GH, vd Mark TW, Sluiter HJ, de Vries K.
    J Allergy Clin Immunol; 1985 Oct 15; 76(4):628-36. PubMed ID: 4056250
    [Abstract] [Full Text] [Related]

  • 20. Effects of treatment with formoterol on bronchoprotection against methacholine.
    Lipworth B, Tan S, Devlin M, Aiken T, Baker R, Hendrick D.
    Am J Med; 1998 May 15; 104(5):431-8. PubMed ID: 9626025
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.